Venous Thromboembolism Prophylaxis Strategies for People Undergoing Elective Total Hip Replacement: A Systematic Review and Network Meta-Analysis
- PMID: 31426937
- DOI: 10.1016/j.jval.2019.02.013
Venous Thromboembolism Prophylaxis Strategies for People Undergoing Elective Total Hip Replacement: A Systematic Review and Network Meta-Analysis
Abstract
Objectives: To assess the efficacy and safety of venous thromboembolism prophylaxis in people undergoing elective total hip replacement.
Methods: Systematic review and Bayesian network meta-analyses of randomized controlled trials were conducted for 3 outcomes: deep vein thrombosis (DVT), pulmonary embolism (PE), and major bleeding (MB). MEDLINE, EMBASE, and Cochrane Library (CENTRAL) databases were searched. Study quality was assessed using the Cochrane risk-of-bias checklist. Fixed- and random-effects models were fitted and compared. The median relative risk (RR) and odds ratio (OR) compared with no prophylaxis, with their 95% credible intervals (CrIs), rank, and probability of being the best, were calculated.
Results: Forty-two (n = 24 374, 26 interventions), 30 (n = 28 842, 23 interventions), and 24 (n = 31 792, 15 interventions) randomized controlled trials were included in the DVT, PE, and MB networks, respectively. Rivaroxaban had the highest probability of being the most effective intervention for DVT (RR 0.06 [95% CrI 0.01-0.29]). Strategy of low-molecular-weight heparin followed by aspirin had the highest probability of reducing the risk of PE and MB (RR 0.0011 [95% CrI 0.00-0.096] and OR 0.37 [95% CrI 0.00-26.96], respectively). The ranking of efficacy estimates across the 3 networks, particularly PE and MB, had very wide CrIs, indicating high degree of uncertainty.
Conclusions: A strategy of low-molecular-weight heparin given for 10 days followed by aspirin for 28 days had the best benefit-risk balance, with the highest probability of being the best on the basis of the results of the PE and MB network meta-analyses. Nevertheless, there is considerable uncertainty around the median ranks of the interventions.
Keywords: deep vein thrombosis; direct-acting oral anticoagulants; hospital-acquired thrombosis; network meta-analysis; orthopedics; pulmonary embolism; systematic review; total hip replacement; venous thromboembolism.
Copyright © 2019 ISPOR–The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Venous thromboembolism prophylaxis strategies for people undergoing elective total knee replacement: a systematic review and network meta-analysis.Lancet Haematol. 2019 Oct;6(10):e530-e539. doi: 10.1016/S2352-3026(19)30155-3. Epub 2019 Aug 20. Lancet Haematol. 2019. PMID: 31444124
-
Clinical Effectiveness and Safety of Aspirin for Venous Thromboembolism Prophylaxis After Total Hip and Knee Replacement: A Systematic Review and Meta-analysis of Randomized Clinical Trials.JAMA Intern Med. 2020 Mar 1;180(3):376-384. doi: 10.1001/jamainternmed.2019.6108. JAMA Intern Med. 2020. PMID: 32011647 Free PMC article.
-
Efficacy and safety of aspirin and rivaroxaban for venous thromboembolism prophylaxis after total hip or knee arthroplasty: A protocol for meta-analysis.Medicine (Baltimore). 2020 Dec 4;99(49):e23055. doi: 10.1097/MD.0000000000023055. Medicine (Baltimore). 2020. PMID: 33285683 Free PMC article.
-
Comparative effectiveness of low-molecular-weight heparins versus other anticoagulants in major orthopedic surgery: a systematic review and meta-analysis.Pharmacotherapy. 2012 Sep;32(9):799-808. doi: 10.1002/j.1875-9114.2012.01106.x. Epub 2012 Jun 28. Pharmacotherapy. 2012. PMID: 22744711 Review.
-
Aspirin versus anticoagulation for prevention of venous thromboembolism major lower extremity orthopedic surgery: a systematic review and meta-analysis.J Hosp Med. 2014 Sep;9(9):579-85. doi: 10.1002/jhm.2224. Epub 2014 Jul 17. J Hosp Med. 2014. PMID: 25045166 Review.
Cited by
-
Incidence of Subclinical Deep Vein Thrombosis after Total Hip and Knee Arthroplasty Is Not Correlated with Number of Tranexamic Acid Doses.J Clin Med. 2024 Jun 29;13(13):3834. doi: 10.3390/jcm13133834. J Clin Med. 2024. PMID: 38999401 Free PMC article.
-
Rivaroxaban in Outpatients with Mild or Moderate COVID-19: Rationale and Design of the Study CARE (CARE - Coalition COVID-19 Brazil VIII).Arq Bras Cardiol. 2023 Mar;120(3):e20220431. doi: 10.36660/abc.20220431. Arq Bras Cardiol. 2023. PMID: 37018790 Free PMC article. English, Portuguese.
-
Statistical Fragility of Venous Thromboembolism Prophylaxis Following Total Joint Arthroplasty.Arthroplast Today. 2023 Mar 4;20:101111. doi: 10.1016/j.artd.2023.101111. eCollection 2023 Apr. Arthroplast Today. 2023. PMID: 36923060 Free PMC article.
-
New Oral Anticoagulants for Venous Thromboembolism Prophylaxis in Total Hip and Knee Arthroplasty: A Systematic Review and Network Meta-Analysis.Front Pharmacol. 2022 Jan 17;12:775126. doi: 10.3389/fphar.2021.775126. eCollection 2021. Front Pharmacol. 2022. PMID: 35111051 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
